Page 503 - O_Desenvolvimento_do_Autismo
P. 503
FILIPEK, P.; ACCARDO, P. J.; BARANEK, G. T.; Cook, E. H.; DAWSON,
G.; GORDON, B.; GRAVEL, J. S.; JOHNSON, C. P.; KALLEN, R. J.; LEVY,
S. E.; MINSHEW, N. J.; PRIZANT, B. M.; RAPIN, I.; ROGERS, S. J.;
STONE, W. L.; TEPLIN, S.; TUCHMAN, R. F. e VOLKMAR, F. “The
screening and diagnosis of autistic spectrum disorders.” Journal of Autism
and Developmental Disorders 29, (6), 1999, pp. 439-484.
FINDLING, R. L.; MAXWELL, K.; SCOTESE-WOJTILA, L.; HUANG, J.;
YAMASHITA, T. e WIZNITZER, M. “High-dose pyridoxine and magnesium
administration in children with autistic disorder: an absence of salutary
effects in a double-blind, placebo-controlled study”. Journal of Autism and
Developmental Disorders 27(4), 1997, pp. 467-478.
FLAVELL, J. H. “Metacognition and cognitive monitoring: a new era of
cognitive-developmental inquiry”. American Psychologist 34, 906-911.
_____. “Metacognitive development”. In: J. Scandura e C. Brainerd (eds.).
Structural process theories of complex human behavior. Leyden: Sijthoff,
1978.
FOLSTEIN, S. e ROSEN-SHEIDLEY, B. “Genetics of autism: complex
aetiology for a heterogeneous disorder”. Nature Reviews Genetics 2(12),
2001, pp. 943-955.
FOMBONNE, E. “Is the prevalence of autism increasing?” Journal of Autism
and Developmental Disorders 26, 1996, pp. 673-676.

